PTGX - Company ID 0001377121
The table below shows Protagonist Therapeutics, Inc's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $193.71M | $113.71M | $168.54M | $139.65M | $131.12M | $355.64M |
| Short-term investments | $354.07M | $462.40M | $401.92M | $434.71M | $337.60M | $208.35M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $613.46M |
| $586.42M |
| $602.53M |
| $605.86M |
| $476.77M |
| $570.92M |
| Property, plant & equipment | $3.78M | $4.10M | $4.11M | $3.53M | $2.47M | $1.78M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $697.46M | $701.69M | $718.01M | $742.13M | $603.86M | $614.63M |
| Accounts payable | $8.44M | $5.65M | $3.25M | $2.92M | $3.05M | $3.63M |
| Total current liabilities | $34.55M | $44.94M | $35.51M | $35.11M | $44.58M | $41.58M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $41.99M | $56.25M | $49.99M | $53.08M | $71.94M | $73.31M |
| Retained earnings | -$466.89M | -$426.29M | -$386.95M | -$352.18M | -$472.20M | -$438.99M |
| Total equity | $655.47M | $645.44M | $668.02M | $689.05M | $531.91M | $541.32M |